Andrew Vaillant

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Combination Therapy

Hepatitis B Virus

Top Venues

Hepatology communications

Hepatology (Baltimore, Md.)

ACS infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Matthieu Blanchet, Léna Angelo, Yasmine Tétreault, Marwa Khabir, Camille Sureau, Andrew Vaillant, Patrick Labonté
HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression. Viruses 16 (4) (2024)
Matthieu Blanchet, Léna Angelo, Yasmine Tétreault, Marwa Khabir, Camille Sureau, Andrew Vaillant, Patrick Labonté
HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression. Viruses 16 (4) (2024)
Matthieu Blanchet, Léna Angelo, Yasmine Tétreault, Marwa Khabir, Camille Sureau, Andrew Vaillant, Patrick Labonté
HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression. Viruses 16 (4) (2024)
Michel Bazinet, Mark Anderson, Victor Pântea, Gheorghe Placinta, Iurie Moscalu, Valentin Cebotarescu, Lilia Cojuhari, Pavlina Jimbei, Liviu Iarovoi, Valentina Smesnoi, Tatina Musteata, Alina Jucov, Ulf Dittmer, Jeff Gersch, Vera Holzmayer, Mary Kuhns, Gavin Cloherty, Andrew Vaillant
HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection. Hepatology communications 6 (8) (2022)
Andrew Vaillant
Oligonucleotide-Based Therapies for Chronic HBV Infection: A Primer on Biochemistry, Mechanisms and Antiviral Effects. Viruses 14 (9) (2022)
Michel Bazinet, Victor Pântea, Gheorghe Placinta, Iurie Moscalu, Valentin Cebotarescu, Lilia Cojuhari, Pavlina Jimbei, Liviu Iarovoi, Valentina Smesnoi, Tatiana Musteata, Alina Jucov, Ulf Dittmer, Adalbert Krawczyk, Andrew Vaillant
Benefit of transaminase elevations in establishing functional cure of HBV infection during nap-based combination therapy. Journal of viral hepatitis 28 (5) (2021)
Harel Dahari, Andrew Vaillant, Scott J Cotler
Letter to the Editor: Examining HBV-RNA Kinetics During NA Treatment-Are NAs Multifunctional Antiviral Agents? Hepatology (Baltimore, Md.) 74 (3) (2021)
Michel Bazinet, Mark Anderson, Victor Pântea, Gheorghe Placinta, Iurie Moscalu, Valentin Cebotarescu, Lilia Cojuhari, Pavlina Jimbei, Liviu Iarovoi, Valentina Smesnoi, Tatina Musteata, Alina Jucov, Ulf Dittmer, Jeff Gersch, Vera Holzmayer, Mary Kuhns, Gavin Cloherty, Andrew Vaillant
Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy. Hepatology communications 5 (11) (2021)
Andrew Vaillant
Letter to the Editor: Is the HBsAg response to RO7062931 an antisense effect? Hepatology (Baltimore, Md.) (2021)
Michel Bazinet, Victor Pântea, Valentin Cebotarescu, Lilia Cojuhari, Pavlina Jimbei, Mark Anderson, Jeff Gersch, Vera Holzmayer, Carina Elsner, Adalbert Krawczyk, Mary C Kuhns, Gavin Cloherty, Ulf Dittmer, Andrew Vaillant
Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection. Hepatology communications 5 (2) (2020)
Andrew Vaillant
HBsAg, Subviral Particles, and Their Clearance in Establishing a Functional Cure of Chronic Hepatitis B Virus Infection. ACS infectious diseases 7 (6) (2020)
Andrew Vaillant
REP 2139: Antiviral Mechanisms and Applications in Achieving Functional Control of HBV and HDV Infection. ACS infectious diseases 5 (5) (2018)